Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.4%

3 terminated/withdrawn out of 218 trials

Success Rate

91.2%

+4.6% vs industry average

Late-Stage Pipeline

16%

34 trials in Phase 3/4

Results Transparency

3%

1 of 31 completed trials have results

Key Signals

77 recruiting1 with results

Enrollment Performance

Analytics

N/A
68(44.7%)
Phase 2
41(27.0%)
Phase 3
23(15.1%)
Phase 4
11(7.2%)
Phase 1
5(3.3%)
Early Phase 1
4(2.6%)
152Total
N/A(68)
Phase 2(41)
Phase 3(23)
Phase 4(11)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (218)

Showing 20 of 218 trials
NCT07735689Not Yet Recruiting

Evaluate the Value of Modified Shock Index in Predicting the Incidence of Cardiovascular Events After Non-cardiac Surgery in Cardiac Patients

Role: lead

NCT07272499Phase 2Recruiting

Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease

Role: collaborator

NCT06862960Phase 2Recruiting

Ozanimod in Patients With Alzheimer's Disease

Role: collaborator

NCT07722091Not ApplicableNot Yet Recruiting

Intraperitoneal Dexamethasone Spraying on Vagal Nerve-Rich Areas for Prevention of Hoarseness After Upper Abdominal Surgery

Role: lead

NCT07672210Recruiting

PregnAncy-Related Aortic DISsEction in China

Role: collaborator

NCT07710001Not ApplicableTerminated

Study on Influencing Factors and Intervention of Silent Aspiration After Heart Valve Operation in Elderly Patients

Role: lead

NCT06577792Not ApplicableActive Not Recruiting

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

Role: collaborator

NCT07665619Early Phase 1Not Yet Recruiting

Clinical Efficacy of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Combined With Sodium Hyaluronate Intravesical Instillation in the Treatment of Radiation Cystitis

Role: lead

NCT07679256Recruiting

Integrated Digital and Neurogenic Exosome Biomarkers for Early Diagnosis of Parkinson's Disease: Development and Application

Role: lead

NCT07679243Phase 1Not Yet Recruiting

A Clinical Study on the Safety and Efficacy of Wide-Band Ultrasound Combined With Traditional Chinese Medicine Preparations in the Prevention and Treatment of Keloids

Role: lead

NCT07672496Not ApplicableNot Yet Recruiting

Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection

Role: lead

NCT07588360Not ApplicableRecruiting

Haplo-Cord HSCT for AML/MDS

Role: lead

NCT07588763Not Yet Recruiting

A Multimodal Convergent Cohort of Parkinson's Disease at FJMUUH (FJMUUH-PD): Natural History Study

Role: lead

NCT06061627Not ApplicableRecruiting

A Randomized Controlled Trial of LOT-CRT Versus conventionaL BiVP in Heart Failure Patients With NICD

Role: collaborator

NCT07587944Recruiting

Biomarkers in Bone Marrow Supernatant for Predicting AML Chemosensitivity

Role: lead

NCT05572957Not ApplicableActive Not Recruiting

LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB

Role: collaborator

NCT04624763Not ApplicableActive Not Recruiting

Protection of Cardiac Function With Left Bundle Branch Pacing in Patients With Atrioventricular Block

Role: collaborator

NCT07576543Phase 4Not Yet Recruiting

Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

Role: collaborator

NCT07576517Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine and tDCS for Prevention of Neurocognitive Complications After Surgery

Role: collaborator

NCT07577050Phase 2Not Yet Recruiting

A Phase II Study of NB001 for Acute Migraine Treatment

Role: collaborator